MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

MEI Pharma Company Profile (NASDAQ:MEIP)

Consensus Ratings for MEI Pharma (NASDAQ:MEIP) (?)
Ratings Breakdown: 1 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $2.00 (47.06% upside)

Analysts' Ratings History for MEI Pharma (NASDAQ:MEIP)
Show:
DateFirmActionRatingPrice TargetActions
4/18/2016WedbushLower Price TargetNeutral$3.00 -> $2.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/7/2015Cowen and CompanyReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/2/2015Cantor FitzgeraldReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/24/2015Bank of AmericaDowngradeBuy -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/24/2015Wells FargoDowngradeOutperform -> Market Perform$2.25 -> $2.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/23/2015Stifel NicolausDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/23/2015Roth CapitalDowngradeBuy -> Neutral$14.00 -> $2.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/8/2014Brean CapitalInitiated CoverageBuy$16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/26/2014 forward)
Earnings History for MEI Pharma (NASDAQ:MEIP)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
9/2/2015($0.23)($0.17)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
9/10/2014($0.37)($0.40)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for MEI Pharma (NASDAQ:MEIP)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividend History for MEI Pharma (NASDAQ:MEIP)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for MEI Pharma (NASDAQ:MEIP)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
11/9/2015Vivo Ventures Vii, LlcMajor ShareholderSell390,572$1.84$718,652.48View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/21/2015Charles V Baltic IIIDirectorBuy5,000$3.81$19,050.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/9/2014Leaf Ventures Ii L.P. NewMajor ShareholderSell79,085$6.01$475,300.85View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/8/2014Leaf Ventures Ii L.P. NewMajor ShareholderSell9,004$6.05$54,474.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/30/2014Charles V Baltic IIIDirectorBuy2,000$6.56$13,120.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/29/2013Vivo Ventures Vii, LlcMajor ShareholderSell299,609$8.21$2,459,789.89View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/2/2013Vivo Ventures Vii, LlcMajor ShareholderSell581,646$10.16$5,909,523.36View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/16/2013Charles V Baltic IIIDirectorBuy2,600$6.82$17,732.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/28/2013Vivo Ventures Vii, LlcMajor ShareholderSell7,337$7.58$55,614.46View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/11/2013Vivo Ventures V, LlcMajor ShareholderSell13,727$7.80$107,070.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/16/2013Vivo Ventures Vii, LlcMajor ShareholderSell17,428$9.07$158,071.96View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/8/2013Leaf Ventures Ii L.P. NewMajor ShareholderSell200,000$8.58$1,716,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/25/2013Charles V Baltic IIIDirectorBuy10,200$6.04$61,608.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/21/2012Charles V Baltic IIIDirectorBuy3,500$7.18$25,130.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for MEI Pharma (NASDAQ:MEIP)
DateHeadline
06/24/16 05:06 PMShare Volatility Check for: MEI Pharma, Inc. (NASDAQ:MEIP) - Press Telegraph
06/22/16 09:51 AMStrong Buy Calls Count For MEI Pharma, Inc. (NASDAQ:MEIP) At 0 - Investor Newswire
06/21/16 09:35 AMAnalyst Views For The Week Ahead: MEI Pharma, Inc. (MEIP) - Fiscal Standard - Financial Market News For Investors ... - Fiscal Standard
06/13/16 08:02 AMStocks Gapping Up Today – KELYB, CERU, LOAN, CHKE, MEIP, CBK, ATEA
06/06/16 08:50 AMBroker Outlook For The Week Ahead MEI Pharma, Inc. (MEIP) - Share Trading News
06/03/16 05:33 PMEarnings Trend per share for Investors: MEI Pharma, Inc. (NASDAQ:MEIP), Voya Financial, Inc. (NYSE:VOYA) - Beacon Chronicle
06/02/16 05:28 PMSome Ideas For The Next Celator - Seeking Alpha - Seeking AlphaSome Ideas For The Next CelatorSeeking AlphaCelator Pharmaceuticals is being acquired by Jazz Pharmaceuticals capping a more than 1500% rise in Celator's share price in just a few months. Biotech deals are likely to continue due to a scarcity of viable mid-to-late stage pipeline candidates in ...and more »
06/02/16 08:01 AMMEI Pharma, Inc. (NASDAQ:MEIP) Stock Update & Estimates - Stock Tick Tock - MEI Pharma, Inc. (NASDAQ:MEIP) Stock Update & EstimatesStock Tick TockThe consensus on Wall Street is expecting MEI Pharma, Inc. (NASDAQ:MEIP) to post earnings of $-0.16 per share when the firm next reports it's fiscal quarterly results. According to the latest information available the report will likely be issued ...and more »
05/31/16 09:14 AMStock Review and Earnings Check on MEI Pharma, Inc. (NASDAQ:MEIP) - HNN - Stock Review and Earnings Check on MEI Pharma, Inc. (NASDAQ:MEIP)HNNInvestors and analysts are typically super focused on company earnings numbers when they are reported. Company earnings are a good way to evaluate the company profitability. Currently, sell-side analysts are expecting MEI Pharma, Inc. (NASDAQ:MEIP) ...and more »
05/30/16 09:59 PMTarget Check and Stock Performance Recap MEI Pharma, Inc. (NASDAQ:MEIP) - HNN - Target Check and Stock Performance Recap MEI Pharma, Inc. (NASDAQ:MEIP)HNNTracking stock performance from various views may help with share evaluation. Some investors might be more focused on short-term share action while others may prefer to view long-term performance. In recent session activity, MEI Pharma, Inc.and more »
05/25/16 06:57 PMStock Rating Review for MEI Pharma, Inc. (NASDAQ:MEIP) - Wall Street Hints and News - Stock Rating Review for MEI Pharma, Inc. (NASDAQ:MEIP)Wall Street Hints and NewsCovering equity analysts presently have a consensus stock rating of 3 on shares of MEI Pharma, Inc. (NASDAQ:MEIP). Covering analysts will often provide Sell, Hold, or Buy recommendations based on their advanced research. This consensus rating is ...and more »
05/25/16 06:57 PMNew Broker Ratings For MEI Pharma, Inc. (MEIP) - FTSE News - New Broker Ratings For MEI Pharma, Inc. (MEIP)FTSE News09/10/2014 – MEI Pharma, Inc. had its “buy” rating reiterated by analysts at Brean Capital. They now have a USD 16 price target on the stock. The share price of MEI Pharma, Inc. (MEIP) was up +0.72% during the last trading session, with a day high of 1.44.
05/24/16 07:15 PMEarnings Review and Stock Rundown for MEI Pharma, Inc. (NASDAQ:MEIP) - Wall Street Hints and News - Earnings Review and Stock Rundown for MEI Pharma, Inc. (NASDAQ:MEIP)Wall Street Hints and NewsInvestors and analysts will be paying close attention when the company posts earnings results. Earnings numbers can provide insight into a company's overall profitability. Covering equity analysts are expecting MEI Pharma, Inc. (NASDAQ:MEIP) to post ...and more »
05/23/16 12:20 PMTarget Check and Stock Performance Recap MEI Pharma, Inc. (NASDAQ:MEIP) - Wall Street Hints and News - Target Check and Stock Performance Recap MEI Pharma, Inc. (NASDAQ:MEIP)Wall Street Hints and NewsTracking stock performance from various views may help with share evaluation. Some investors might be more focused on short-term share action while others may prefer to view long-term performance. In recent session activity, MEI Pharma, Inc.and more »
05/21/16 06:35 PMAlpha One Assigns Impact Score Of 100 To MEI Pharma, Inc. (NASDAQ:MEIP) - RealistInvestor.com - Alpha One Assigns Impact Score Of 100 To MEI Pharma, Inc. (NASDAQ:MEIP)RealistInvestor.comAlpha One analyzed the various web articles published on MEI Pharma, Inc. (NASDAQ:MEIP), and thereafter it gave company a daily sentiment score of 0. The entity designs algorithm based assessment to known stock sentiment on stock after considering the ...and more »
05/18/16 07:03 PMRevenue Update on MEI Pharma Inc(NASDAQ:MEIP) - Trade Calls - Revenue Update on MEI Pharma Inc(NASDAQ:MEIP)Trade CallsMEI Pharma Inc(NASDAQ:MEIP) announced the earnings results for Fiscal Year 2016 and Q3. The results came in during Pre-market on May 5, 2016. Earnings per share were $-0.16. Analysts had estimated an EPS of $-0.16. MEI Pharma Inc (MEIP) shares ...Share Recap and Earnings Focus on MEI Pharma, Inc. (NASDAQ:MEIP)Wall Street Hints and Newsall 2 news articles »
05/17/16 11:16 AMShare Recap and Earnings Focus on MEI Pharma, Inc. (NASDAQ:MEIP) - Wall Street Hints and News - Share Recap and Earnings Focus on MEI Pharma, Inc. (NASDAQ:MEIP)Wall Street Hints and NewsAnalysts and investors are usually very focused on company earnings numbers when they are released. Company earnings are a good way to evaluate the profitability of the company. Presently, covering analysts are anticipating MEI Pharma, Inc.and more »
05/08/16 09:19 PMNext Weeks Broker Price Targets For MEI Pharma, Inc. (MEIP) - Share Trading News - Next Weeks Broker Price Targets For MEI Pharma, Inc. (MEIP)Share Trading NewsMEI Pharma, Inc. has a 50 day moving average of 1.38 and a 200 day moving average of 1.46. The stock's market capitalization is 45.77M, it has a 52-week low of 0.87 and a 52-week high of 2.12. The share price of the company (MEIP) was down -2.19%, ...and more »
05/07/16 06:34 PMMEI Pharma, Inc. (NASDAQ:MEIP) Boasts An Average Rating Of 5 - RealistInvestor.com - MEI Pharma, Inc. (NASDAQ:MEIP) Boasts An Average Rating Of 5RealistInvestor.comAlpha One applies algorithm-based analytics for assessing a stock sentiment as per the published released on web channels. In this evaluation process, the group accesses the most relevant news platforms on a daily basis. MEI Pharma, Inc. (NASDAQ:MEIP) ...and more »
05/04/16 12:33 AMAverage Analyst Rating for MEI Pharma, Inc. (NASDAQ:MEIP) - B.O.D.Y Confidential - Average Analyst Rating for MEI Pharma, Inc. (NASDAQ:MEIP)B.O.D.Y ConfidentialWall Street analysts have provided an average broker recommendation of 3 on MEI Pharma, Inc. (NASDAQ:MEIP) shares. The rating is determined by using the average of all analyst recommendations taken into consideration by Zacks Research.and more »
05/02/16 02:24 AMMEI Pharma, Inc. (MEIP) Broker Price Targets For The Coming Week - Share Trading News - MEI Pharma, Inc. (MEIP) Broker Price Targets For The Coming WeekShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of MEI Pharma, Inc. (MEIP). The latest reports which are currently in issue on Monday 2nd of May state 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 ...Mei Pharma Incorporated (NASDAQ:MEIP) Shorts Decreased by 10.94% After Short CoveringB.O.D.Y Confidentialall 2 news articles »
04/30/16 07:17 PMMEI Pharma, Inc. (NASDAQ:MEIP) Has An Impact Score Of 79 - RealistInvestor.com - MEI Pharma, Inc. (NASDAQ:MEIP) Has An Impact Score Of 79RealistInvestor.comMEI Pharma, Inc. (NASDAQ:MEIP) has been given a 0 daily sentiment score for the related articles published on web today. Alpha One offer algorithm-based analytics, which can help state stock sentiment based on the content published on different online ...
04/27/16 02:39 AMMEI Pharma, Inc. (NASDAQ:MEIP) Share Rating Recap - B.O.D.Y Confidential - MEI Pharma, Inc. (NASDAQ:MEIP) Share Rating RecapB.O.D.Y ConfidentialShares of MEI Pharma, Inc. (NASDAQ:MEIP) are tracked by analysts as well as crowd investors. Research from Beta Systems keeps track of crowd sourced sentiment and provides consensus stock ratings. The rating information comes mainly from financial ...and more »
04/26/16 07:23 PMCurrent Price Targets For MEI Pharma, Inc. (MEIP) - Risers & Fallers - Current Price Targets For MEI Pharma, Inc. (MEIP)Risers & FallersRecently stock market analysts have updated their consensus ratings on shares of MEI Pharma, Inc. (MEIP). The latest broker reports which are currently outstanding on Tuesday 26th of April state 0 analysts have a rating of “strong buy”, 0 analysts “buy ...and more »
04/22/16 09:30 PMMEI Pharma, Inc. (NASDAQ:MEIP) Analyst Rating Review - B.O.D.Y Confidential - MEI Pharma, Inc. (NASDAQ:MEIP) Analyst Rating ReviewB.O.D.Y ConfidentialCovering analysts typically give Buy, Sell and Hold recommendations along with guidance and company earnings projections. Currently, there are 1 analysts that have provided ratings for MEI Pharma, Inc. (NASDAQ:MEIP). 0 have rated the stock a “Strong ...and more »
04/22/16 09:30 PMLatest Analyst Reports On MEI Pharma, Inc. - Risers & Fallers - Latest Analyst Reports On MEI Pharma, Inc.Risers & FallersMEI Pharma, Inc. has a 50 day moving average of 1.31 and a 200 day moving average of 1.48. The stock's market capitalization is 51.92M, it has a 52-week low of 0.87 and a 52-week high of 2.20. The share price of the company (MEIP) was down -0.65%, ...
04/21/16 09:16 PMMEI Pharma, Inc. (NASDAQ:MEIP) Share Rating Recap - The Post - MEI Pharma, Inc. (NASDAQ:MEIP) Share Rating RecapThe PostShares of MEI Pharma, Inc. (NASDAQ:MEIP) are tracked by analysts as well as crowd investors. Research from Beta Systems keeps track of crowd sourced sentiment and provides consensus stock ratings. The rating information comes mainly from financial ...and more »
04/21/16 09:16 PMAnalyst Review: MEI Pharma, Inc. (MEIP) - Risers & Fallers - Mas Market NewsAnalyst Review: MEI Pharma, Inc. (MEIP)Risers & FallersA number of investment brokers have recently updated their price targets on shares of MEI Pharma, Inc. (MEIP). According to the latest broker reports outstanding on Thursday 21st of April, 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 ...MEI Pharma Inc (MEIP) PT Lowered to $2.00 at WedbushMas Market Newsall 2 news articles »
04/20/16 08:37 PMCompany Update (NASDAQ:MEIP): MEI Pharma Inc Announces New Clinical Data from First-in-Human Study of ME-401 - Smarter Analyst - Smarter AnalystCompany Update (NASDAQ:MEIP): MEI Pharma Inc Announces New Clinical Data from First-in-Human Study of ME-401Smarter AnalystMEI Pharma Inc (NASDAQ:MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced new clinical data from a first-in-human study of MEI Pharma's investigational drug candidate, ME-401, a next generation ...MEI Pharma Inc (MEIP) Price Target Cut to $2.00Web Breaking NewsMEI Pharma Announces New Clinical Data from First-in-Human Study of ME-401, A Next Generation Oral PI3K Delta ...PR Newswire (press release)MEI Pharma Reports Clinical Data from First-in-Human Study of ME-401 at AACR 2016; Stock Gains 1.4% (NASDAQ ...Sonoran Weekly Reviewall 4 news articles »
04/20/16 07:21 AMMEI Pharma Announces New Clinical Data from First-in-Human Study of ME-401, A Next Generation Oral PI3K Delta Inhibitor - [at noodls] - SAN DIEGO, April 20, 2016/PRNewswire / -- MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced new clinical data from a first-in-human ...
04/20/16 07:04 AM8:04 am MEI Pharma announces new clinical data from a Phase I study of its investigational drug candidate, ME-401; well tolerated at all levels -
04/19/16 09:29 PMMEI Pharma Inc (MEIP) Poised To Move Higher; Here's Why - Smarter Analyst - Smarter AnalystMEI Pharma Inc (MEIP) Poised To Move Higher; Here's WhySmarter AnalystHaving seen the updated Pracinostat overall survival data in elderly Acute Myeloid Leukemia (AML) from MEI Pharma (NASDAQ:MEIP) presented at the recent Needham Healthcare Conference, I believe this is another opportunity to buy a severely ...
04/16/16 06:58 PMAnalysts Ranking Activities: MEI Pharma, Inc. (NASDAQ:MEIP) , BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - Street Updates - Analysts Ranking Activities: MEI Pharma, Inc. (NASDAQ:MEIP) , BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Street UpdatesOn 4/15/2016, shares of MEI Pharma, Inc. (NASDAQ:MEIP) fell -2.44% in trading session and finally closed at $1.60. The company most recent volume stood at 1.13 million shares as compared to average volume of 181.91 thousand shares. Over the one year ...and more »
04/15/16 08:54 PMMEI Pharma, Inc. (MEIP) Updated Broker Price Targets - Share Trading News - MEI Pharma, Inc. (MEIP) Updated Broker Price TargetsShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of MEI Pharma, Inc. (MEIP). The latest reports which are currently in issue on Friday 15th of April state 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 ...MEI Pharma, Inc. (NASDAQ:MEIP): Quick Look at EarningsNews Tribuneall 2 news articles »
04/14/16 01:40 AMView on Ratings MEI Pharma, Inc. (NASDAQ:MEIP) - Business Standard Tribune - View on Ratings MEI Pharma, Inc. (NASDAQ:MEIP)Business Standard TribuneUsing a scale from 1 to 5, MEI Pharma, Inc. (NASDAQ:MEIP) has a rating of 3 on the stock. A score of 1 or 2 indicates a Buy rating, and a score of 4 or 5 indicates a Sell rating. A 3 would indicate a Hold. This consensus number is made up of covering ...Broker Roundup For MEI Pharma, Inc. (MEIP)Share Trading NewsMei Pharma Incorporated (NASDAQ:MEIP) Shorted Shares Decreased By 8.98%Franklin Independentall 3 news articles »
04/12/16 08:55 PMEarnings Watch on MEI Pharma, Inc. (NASDAQ:MEIP) - RiversideGazette.com - Earnings Watch on MEI Pharma, Inc. (NASDAQ:MEIP)RiversideGazette.comMEI Pharma, Inc. (NASDAQ:MEIP) has a consensus earnings per share estimate for the current quarter of $-0.15 based on compiled analyst projections. The company is next expected to release earnings on or around 2016-05-05 for the period ending ...and more »
04/12/16 01:26 AMBroker Changes For MEI Pharma, Inc. (MEIP) - Risers & Fallers - Broker Changes For MEI Pharma, Inc. (MEIP)Risers & FallersRecently stock market analysts have updated their consensus ratings on shares of MEI Pharma, Inc. (MEIP). The latest broker reports which are currently outstanding on Monday 11th of April state 0 analysts have a rating of “strong buy”, 0 analysts “buy ...MEI Pharma, Inc. (NASDAQ:MEIP) To Pay Dividend Of $N/AEnterprise LeaderMei Pharma Inc (NASDAQ:MEIP) Q3 2015 Sentiment ChangeSmallCapWired.comall 3 news articles »
04/08/16 09:47 PMBroker Roundup For MEI Pharma, Inc. (MEIP) - Share Trading News - Broker Roundup For MEI Pharma, Inc. (MEIP)Share Trading NewsRecently some investment brokers have made changes to their outstanding price targets on shares of MEI Pharma, Inc. (MEIP). According to data from Reuters, 0 analysts have a rating of “buy”, 0 analysts “outperform”, 3 analysts “hold”, 0 analysts ...and more »
04/08/16 09:47 PMIs MEI Pharma, Inc. (NASDAQ:MEIP) a Consensus Buy? - Clinton Financial - Is MEI Pharma, Inc. (NASDAQ:MEIP) a Consensus Buy?Clinton FinancialEquity research firms covering public U.S companies have a workforce of analysts dedicating their time covering the most popular stocks. Their reports are delivered to institutional investors in order to help make investment decisions. The information ...and more »
04/05/16 08:23 PMEarnings View for MEI Pharma, Inc. (NASDAQ:MEIP) - RiversideGazette.com - Earnings View for MEI Pharma, Inc. (NASDAQ:MEIP)RiversideGazette.comWall Street analysts have a current quarter EPS estimate of $-0.15 on shares of MEI Pharma, Inc. (NASDAQ:MEIP). Analysts and investors will be looking ahead to the next company earnings report which is scheduled to be released on or around 2016-05-05 ...and more »
03/22/16 07:02 AMMEI PHARMA, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial State -
02/11/16 12:04 PMMEI PHARMA, INC. Financials -
02/05/16 07:03 AMMEI PHARMA, INC. Files SEC form 10-Q, Quarterly Report -
02/01/16 08:41 AMMEI Pharma to Present at BIO CEO & Investor Conference - [at noodls] - MEI Pharma to Present at BIO CEO & Investor Conference
12/12/15 09:25 AM5 Key BioPharma Movers That Cannot Be Ignored -
12/10/15 07:49 AMMEI Pharma Appoints Dr. Christine White as Chairman of the Board - [at noodls] - SAN DIEGO, Dec. 10, 2015/PRNewswire / -- MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, today announced the appointment of Christine ...
12/10/15 07:32 AMMEI PHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits -
12/09/15 07:00 AMMEI Pharma (MEIP) Worth Watching: Stock Gains 5.4% -
12/09/15 05:37 AMMEI Pharma to Host Annual Meeting of Stockholders - [at noodls] - SAN DIEGO, Nov. 23, 2015/PRNewswire / -- MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, will host its Annual Meeting of Stockholders ...
12/09/15 05:37 AMMEI Pharma Announces Positive Results from Phase II Study of Pracinostat in Acute Myeloid Leukemia, Plans to Initiate Phase III Registration Study - [at noodls] - SAN DIEGO, Dec. 7, 2015/PRNewswire / -- MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, today announced positive results from a Phase ...
About MEI Pharma

MEI Pharma logoMEI Pharma, Inc. is an oncology company. The Company is focused on the clinical development of drugs and therapies for treatment of cancer. The Company's portfolio of clinical drug candidates includes Pracinostat, ME-344 and PWT143. Pracinostat is an orally available histone deacetylase (HDAC) inhibitor indicated for the treatment of advanced hematologic diseases, such as acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). ME-344 is an isoflavone-based mitochondrial inhibitor targeting a mitochondrial component of the terminal respiratory chain complex in rapidly proliferating cells. PWT143 is an oral inhibitor of phosphatidylinositide 3-kinase (PI3K) delta, a molecular target that plays a critical role in the proliferation and survival of hematologic cancer cells. Pracinostat has been tested in multiple Phase I and Phase II clinical trials in advanced hematologic malignancies and solid tumor indications.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Drug Manufacturers - Other
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: MEIP
  • CUSIP:
Key Metrics:
  • Previous Close: $1.36
  • 50 Day Moving Average: $1.38
  • 200 Day Moving Average: $1.37
  • P/E Ratio: N/A
  • P/E Growth: 20.90
  • Market Cap: $46.45M
  • Current Quarter EPS Consensus Estimate: $-0.64 EPS
Additional Links:
MEI Pharma (NASDAQ:MEIP) Chart for Sunday, June, 26, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha